Thyroid Cancer (Pilot)
Pilot - Not Accredited
Thyroid papillary carcinoma, thyroid follicular carcinoma, poorly differentiated anaplastic thyroid carcinoma, thyroid medullary carcinoma, Phaeochromocytoma, adrenal cortical carcinoma, RET, BRAF, KRAS, NRAS, HRAS, TP53, KRAS, TERT promoter
PURPOSE OF PROGRAMME:
Testing for somatic small nucelotide variants in thryoid cancer.
MATERIAL PROVIDED: DNA in TE buffer
DISTRIBUTIONS PER YEAR: 1
SAMPLES PER DISTRIBUTION: 3
FREQUENCY OF DISTRIBUTION: 1
PROGRAMME OF ANALYSIS:
Small variant analysis only
Details of the performance criteria for this programme can be obtained from UK NEQAS Genomics (GenQA) directly.
Telephone: +44 (0) 131 2426898
From 1st January 2018, Cytogenomics External Quality Assessment Service (CEQAS) and UK National External Quality Assessment Service (UK NEQAS) for Molecular Genetics merged to become Genomics Quality Assessment (GenQA). Please click here for an overview of GenQA